View ValuationLier ChemicalLTD 향후 성장Future 기준 점검 2/6Lier ChemicalLTD (는) 각각 연간 20.8% 및 9.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 20.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.8% 로 예상됩니다.핵심 정보20.8%이익 성장률20.95%EPS 성장률Chemicals 이익 성장30.5%매출 성장률9.4%향후 자기자본이익률8.79%애널리스트 커버리지Low마지막 업데이트28 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Mar 31Lier Chemical Co.,LTD. to Report Q1, 2026 Results on Apr 25, 2026Lier Chemical Co.,LTD. announced that they will report Q1, 2026 results on Apr 25, 2026공시 • Mar 28Lier Chemical Co.,LTD., Annual General Meeting, Apr 17, 2026Lier Chemical Co.,LTD., Annual General Meeting, Apr 17, 2026, at 14:40 China Standard Time. Location: 7F, Building 1, No. 16, Yuanyi Street, Pucheng District, Mianyang, Sichuan China공시 • Dec 31Lier Chemical Co.,LTD. to Report Fiscal Year 2025 Results on Mar 28, 2026Lier Chemical Co.,LTD. announced that they will report fiscal year 2025 results on Mar 28, 2026공시 • Sep 30Lier Chemical Co.,LTD. to Report Q3, 2025 Results on Oct 25, 2025Lier Chemical Co.,LTD. announced that they will report Q3, 2025 results on Oct 25, 2025공시 • Sep 16Lier Chemical Co.,Ltd. Approves Interim Profit Distribution Plan for 2025Lier Chemical Co.,LTD. held its 2nd Extraordinary General Meeting of 2025 on 12 September 2025, approved cash interim dividend (tax included) of CNY 2.00000000 per 10 shares for the year 2025.공시 • Aug 28Lier Chemical Co.,LTD. Approves Board Appointments, Effective 26 August 2025Lier Chemical Co.,LTD. at its Extraordinary General Meeting held on 26 August 2025, approved election of Wei Dejia and Meng Qin as independent directors.공시 • Jul 02Lier Chemical Co.,LTD. to Report First Half, 2025 Results on Aug 28, 2025Lier Chemical Co.,LTD. announced that they will report first half, 2025 results on Aug 28, 2025공시 • Apr 23Lier Chemical Co.,LTD. Approves Cash Dividend for the Year 2024Lier Chemical Co.,LTD. approved cash dividend of CNY 2.00000000 per 10 shares (tax included) for the year 2024, at its AGM held on 18 April 2025.공시 • Mar 31Lier Chemical Co.,LTD. to Report Q1, 2025 Results on Apr 25, 2025Lier Chemical Co.,LTD. announced that they will report Q1, 2025 results on Apr 25, 2025공시 • Mar 28Lier Chemical Co.,LTD., Annual General Meeting, Apr 18, 2025Lier Chemical Co.,LTD., Annual General Meeting, Apr 18, 2025, at 14:40 China Standard Time. Location: The Company's Meeting Room, Mianyang, Sichuan China공시 • Dec 31Lier Chemical Co.,LTD. to Report Fiscal Year 2024 Results on Mar 28, 2025Lier Chemical Co.,LTD. announced that they will report fiscal year 2024 results on Mar 28, 2025Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.049 (vs CN¥0.10 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.049 (down from CN¥0.10 in 3Q 2023). Revenue: CN¥1.86b (up 21% from 3Q 2023). Net income: CN¥39.0m (down 51% from 3Q 2023). Profit margin: 2.1% (down from 5.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.공시 • Sep 30Lier Chemical Co.,LTD. to Report Q3, 2024 Results on Oct 31, 2024Lier Chemical Co.,LTD. announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥8.02, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years.Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.056 (vs CN¥0.26 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.056 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.94b (down 4.4% from 2Q 2023). Net income: CN¥45.1m (down 78% from 2Q 2023). Profit margin: 2.3% (down from 10% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 31% per year, which means it is performing significantly worse than earnings.공시 • Jun 29Lier Chemical Co.,LTD. to Report First Half, 2024 Results on Aug 30, 2024Lier Chemical Co.,LTD. announced that they will report first half, 2024 results on Aug 30, 2024Reported Earnings • Apr 29First quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.34 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.34 in 1Q 2023). Revenue: CN¥1.39b (down 43% from 1Q 2023). Net income: CN¥47.8m (down 83% from 1Q 2023). Profit margin: 3.4% (down from 11% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings.공시 • Mar 30Lier Chemical Co.,LTD. to Report Q1, 2024 Results on Apr 29, 2024Lier Chemical Co.,LTD. announced that they will report Q1, 2024 results on Apr 29, 2024Reported Earnings • Mar 23Full year 2023 earnings released: EPS: CN¥0.75 (vs CN¥2.43 in FY 2022)Full year 2023 results: EPS: CN¥0.75 (down from CN¥2.43 in FY 2022). Revenue: CN¥7.85b (down 23% from FY 2022). Net income: CN¥603.9m (down 67% from FY 2022). Profit margin: 7.7% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.공시 • Mar 23Lier Chemical Co.,LTD., Annual General Meeting, Apr 12, 2024Lier Chemical Co.,LTD., Annual General Meeting, Apr 12, 2024, at 14:40 China Standard Time.Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥10.13, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.11 per share.Reported Earnings • Feb 01Full year 2023 earnings released: EPS: CN¥0.75 (vs CN¥2.43 in FY 2022)Full year 2023 results: EPS: CN¥0.75 (down from CN¥2.43 in FY 2022). Revenue: CN¥7.85b (down 23% from FY 2022). Net income: CN¥603.9m (down 67% from FY 2022). Profit margin: 7.7% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.공시 • Dec 30Lier Chemical Co.,LTD. to Report Fiscal Year 2023 Results on Mar 23, 2024Lier Chemical Co.,LTD. announced that they will report fiscal year 2023 results on Mar 23, 2024Reported Earnings • Oct 25Third quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.60 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.60 in 3Q 2022). Revenue: CN¥1.54b (down 42% from 3Q 2022). Net income: CN¥80.3m (down 82% from 3Q 2022). Profit margin: 5.2% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.69 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.26 (down from CN¥0.69 in 2Q 2022). Revenue: CN¥2.03b (down 18% from 2Q 2022). Net income: CN¥205.0m (down 60% from 2Q 2022). Profit margin: 10% (down from 21% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.Reported Earnings • Apr 25First quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.72 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.34 (down from CN¥0.72 in 1Q 2022). Revenue: CN¥2.44b (down 6.5% from 1Q 2022). Net income: CN¥274.7m (down 49% from 1Q 2022). Profit margin: 11% (down from 20% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 02Full year 2022 earnings released: EPS: CN¥2.43 (vs CN¥1.46 in FY 2021)Full year 2022 results: EPS: CN¥2.43 (up from CN¥1.46 in FY 2021). Revenue: CN¥10.1b (up 56% from FY 2021). Net income: CN¥1.81b (up 69% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jan 14Full year 2022 earnings released: EPS: CN¥2.43 (vs CN¥1.46 in FY 2021)Full year 2022 results: EPS: CN¥2.43 (up from CN¥1.46 in FY 2021). Revenue: CN¥10.1b (up 56% from FY 2021). Net income: CN¥1.81b (up 69% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. 3 highly experienced directors. Assistant to the General Manager and Member of Supervisory Board Fen Fang Tan is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 13Third quarter 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.14 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.60 (up from CN¥0.14 in 3Q 2021). Revenue: CN¥2.66b (up 138% from 3Q 2021). Net income: CN¥444.5m (up 317% from 3Q 2021). Profit margin: 17% (up from 9.5% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 09Second quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.39 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.39 in 2Q 2021). Revenue: CN¥2.47b (up 47% from 2Q 2021). Net income: CN¥513.3m (up 81% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 11% compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jul 08Second quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.39 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.39 in 2Q 2021). Revenue: CN¥2.47b (up 47% from 2Q 2021). Net income: CN¥513.2m (up 81% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 11% compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥1.01 (vs CN¥0.30 in 1Q 2021)First quarter 2022 results: EPS: CN¥1.01 (up from CN¥0.30 in 1Q 2021). Revenue: CN¥2.61b (up 76% from 1Q 2021). Net income: CN¥534.3m (up 142% from 1Q 2021). Profit margin: 20% (up from 15% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 4.4% compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Apr 06Upcoming dividend of CN¥0.50 per shareEligible shareholders must have bought the stock before 13 April 2022. Payment date: 13 April 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Chinese dividend payers (2.0%). Higher than average of industry peers (1.4%).Reported Earnings • Mar 06Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥2.04 (up from CN¥1.17 in FY 2020). Revenue: CN¥6.49b (up 31% from FY 2020). Net income: CN¥1.07b (up 75% from FY 2020). Profit margin: 17% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 13%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 33% per year.Reported Earnings • Jan 23Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥2.04 (up from CN¥1.17 in FY 2020). Revenue: CN¥6.49b (up 31% from FY 2020). Net income: CN¥1.07b (up 75% from FY 2020). Profit margin: 17% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 13%, compared to a 40% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 28% per year.Valuation Update With 7 Day Price Move • Nov 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥27.56, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 66% over the past three years.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.31 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥1.12b (up 11% from 3Q 2020). Net income: CN¥106.7m (down 34% from 3Q 2020). Profit margin: 9.5% (down from 16% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 15% per year.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥28.25, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 51% over the past three years.Reported Earnings • Aug 09Second quarter 2021 earnings released: EPS CN¥0.54 (vs CN¥0.33 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.68b (up 23% from 2Q 2020). Net income: CN¥284.2m (up 65% from 2Q 2020). Profit margin: 17% (up from 13% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥30.04, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.77 per share.Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.16 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.48b (up 51% from 1Q 2020). Net income: CN¥220.8m (up 165% from 1Q 2020). Profit margin: 15% (up from 8.5% in 1Q 2020). The increase in margin was driven by higher revenue.Analyst Estimate Surprise Post Earnings • Mar 07Revenue beats expectationsRevenue exceeded analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 14%, compared to a 51% growth forecast for the Chemicals industry in China.Reported Earnings • Mar 07Full year 2020 earnings released: EPS CN¥1.17 (vs CN¥0.59 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.97b (up 19% from FY 2019). Net income: CN¥612.2m (up 97% from FY 2019). Profit margin: 12% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥25.56, the stock is trading at a trailing P/E ratio of 21.8x, down from the previous P/E ratio of 25.8x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past year are 85%.Is New 90 Day High Low • Feb 20New 90-day high: CN¥30.25The company is up 33% from its price of CN¥22.71 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.22 per share.Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥27.94, the stock is trading at a trailing P/E ratio of 23.8x, up from the previous P/E ratio of 20.3x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 123%.Is New 90 Day High Low • Jan 29New 90-day high: CN¥25.24The company is up 27% from its price of CN¥19.90 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.21 per share.Reported Earnings • Jan 23Full year 2020 earnings released: EPS CN¥1.17The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.97b (up 19% from FY 2019). Net income: CN¥615.2m (up 98% from FY 2019). Profit margin: 12% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue.Analyst Estimate Surprise Post Earnings • Jan 23Revenue beats expectationsRevenue exceeded analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 14%, compared to a 50% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 18% share price gain to CN¥23.71, the stock is trading at a trailing P/E ratio of 25.2x, up from the previous P/E ratio of 21.3x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past year are 109%.Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥493.5m, up 26% from the prior year. Total revenue was CN¥4.50b over the last 12 months, up 5.2% from the prior year.Is New 90 Day High Low • Oct 05New 90-day low: CN¥19.38The company is down 2.0% from its price of CN¥19.85 on 07 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.15 per share.이익 및 매출 성장 예측XSEC:002258 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202812,2008161,2182,007112/31/202710,7507149871,793212/31/202610,1036195091,56223/31/20269,234441301,098N/A12/31/20259,0084792131,297N/A9/30/20258,8324651621,238N/A6/30/20258,488393661,131N/A3/31/20258,006321-697415N/A12/31/20247,311215-870313N/A9/30/20247,032176-890313N/A6/30/20246,711217-1,211121N/A3/31/20246,799377-1,127566N/A12/31/20237,851604-1,034939N/A9/30/20238,400880-1,1321,170N/A6/30/20239,5271,245-1,1201,617N/A3/31/20239,9651,553132,516N/A1/1/202310,1361,8133882,597N/A9/30/20229,9571,9538442,572N/A6/30/20228,4131,6151,1692,339N/A3/31/20227,6251,3865381,446N/A12/31/20216,4941,0725151,317N/A9/30/20215,8888074251,000N/A6/30/20215,779862308873N/A3/31/20215,470750392948N/A12/31/20204,969612444899N/A9/30/20204,499493-162599N/A6/30/20204,4604072675N/A3/31/20204,127322-197454N/A12/31/20194,164311N/A590N/A9/30/20194,278393N/A460N/A6/30/20194,258477N/A347N/A3/31/20194,140534N/A489N/A12/31/20184,027578N/A348N/A9/30/20183,914592N/A607N/A6/30/20183,686513N/A527N/A3/31/20183,463459N/A371N/A12/31/20173,084402N/A363N/A9/30/20172,521302N/A167N/A6/30/20172,283260N/A229N/A3/31/20172,038227N/A240N/A12/31/20161,982208N/A185N/A9/30/20161,797162N/A105N/A6/30/20161,599148N/A73N/A3/31/20161,638149N/A72N/A12/31/20151,489138N/A157N/A9/30/20151,395116N/A135N/A6/30/20151,398108N/A121N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 002258 의 연간 예상 수익 증가율(20.8%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 002258 의 연간 수익(20.8%)이 CN 시장(27%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 002258 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 002258 의 수익(연간 9.4%)이 CN 시장(연간 16.3%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 002258 의 수익(연간 9.4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 002258의 자본 수익률은 3년 후 8.8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/31 04:12종가2026/05/29 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Lier Chemical Co.,LTD.는 10명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Di WuChina International Capital Corporation LimitedTangyi LiChina International Capital Corporation LimitedZhe WangCitic Securities Co., Ltd.7명의 분석가 더 보기
공시 • Mar 31Lier Chemical Co.,LTD. to Report Q1, 2026 Results on Apr 25, 2026Lier Chemical Co.,LTD. announced that they will report Q1, 2026 results on Apr 25, 2026
공시 • Mar 28Lier Chemical Co.,LTD., Annual General Meeting, Apr 17, 2026Lier Chemical Co.,LTD., Annual General Meeting, Apr 17, 2026, at 14:40 China Standard Time. Location: 7F, Building 1, No. 16, Yuanyi Street, Pucheng District, Mianyang, Sichuan China
공시 • Dec 31Lier Chemical Co.,LTD. to Report Fiscal Year 2025 Results on Mar 28, 2026Lier Chemical Co.,LTD. announced that they will report fiscal year 2025 results on Mar 28, 2026
공시 • Sep 30Lier Chemical Co.,LTD. to Report Q3, 2025 Results on Oct 25, 2025Lier Chemical Co.,LTD. announced that they will report Q3, 2025 results on Oct 25, 2025
공시 • Sep 16Lier Chemical Co.,Ltd. Approves Interim Profit Distribution Plan for 2025Lier Chemical Co.,LTD. held its 2nd Extraordinary General Meeting of 2025 on 12 September 2025, approved cash interim dividend (tax included) of CNY 2.00000000 per 10 shares for the year 2025.
공시 • Aug 28Lier Chemical Co.,LTD. Approves Board Appointments, Effective 26 August 2025Lier Chemical Co.,LTD. at its Extraordinary General Meeting held on 26 August 2025, approved election of Wei Dejia and Meng Qin as independent directors.
공시 • Jul 02Lier Chemical Co.,LTD. to Report First Half, 2025 Results on Aug 28, 2025Lier Chemical Co.,LTD. announced that they will report first half, 2025 results on Aug 28, 2025
공시 • Apr 23Lier Chemical Co.,LTD. Approves Cash Dividend for the Year 2024Lier Chemical Co.,LTD. approved cash dividend of CNY 2.00000000 per 10 shares (tax included) for the year 2024, at its AGM held on 18 April 2025.
공시 • Mar 31Lier Chemical Co.,LTD. to Report Q1, 2025 Results on Apr 25, 2025Lier Chemical Co.,LTD. announced that they will report Q1, 2025 results on Apr 25, 2025
공시 • Mar 28Lier Chemical Co.,LTD., Annual General Meeting, Apr 18, 2025Lier Chemical Co.,LTD., Annual General Meeting, Apr 18, 2025, at 14:40 China Standard Time. Location: The Company's Meeting Room, Mianyang, Sichuan China
공시 • Dec 31Lier Chemical Co.,LTD. to Report Fiscal Year 2024 Results on Mar 28, 2025Lier Chemical Co.,LTD. announced that they will report fiscal year 2024 results on Mar 28, 2025
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.049 (vs CN¥0.10 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.049 (down from CN¥0.10 in 3Q 2023). Revenue: CN¥1.86b (up 21% from 3Q 2023). Net income: CN¥39.0m (down 51% from 3Q 2023). Profit margin: 2.1% (down from 5.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.
공시 • Sep 30Lier Chemical Co.,LTD. to Report Q3, 2024 Results on Oct 31, 2024Lier Chemical Co.,LTD. announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥8.02, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years.
Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.056 (vs CN¥0.26 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.056 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.94b (down 4.4% from 2Q 2023). Net income: CN¥45.1m (down 78% from 2Q 2023). Profit margin: 2.3% (down from 10% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 31% per year, which means it is performing significantly worse than earnings.
공시 • Jun 29Lier Chemical Co.,LTD. to Report First Half, 2024 Results on Aug 30, 2024Lier Chemical Co.,LTD. announced that they will report first half, 2024 results on Aug 30, 2024
Reported Earnings • Apr 29First quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.34 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.34 in 1Q 2023). Revenue: CN¥1.39b (down 43% from 1Q 2023). Net income: CN¥47.8m (down 83% from 1Q 2023). Profit margin: 3.4% (down from 11% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings.
공시 • Mar 30Lier Chemical Co.,LTD. to Report Q1, 2024 Results on Apr 29, 2024Lier Chemical Co.,LTD. announced that they will report Q1, 2024 results on Apr 29, 2024
Reported Earnings • Mar 23Full year 2023 earnings released: EPS: CN¥0.75 (vs CN¥2.43 in FY 2022)Full year 2023 results: EPS: CN¥0.75 (down from CN¥2.43 in FY 2022). Revenue: CN¥7.85b (down 23% from FY 2022). Net income: CN¥603.9m (down 67% from FY 2022). Profit margin: 7.7% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.
공시 • Mar 23Lier Chemical Co.,LTD., Annual General Meeting, Apr 12, 2024Lier Chemical Co.,LTD., Annual General Meeting, Apr 12, 2024, at 14:40 China Standard Time.
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥10.13, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.11 per share.
Reported Earnings • Feb 01Full year 2023 earnings released: EPS: CN¥0.75 (vs CN¥2.43 in FY 2022)Full year 2023 results: EPS: CN¥0.75 (down from CN¥2.43 in FY 2022). Revenue: CN¥7.85b (down 23% from FY 2022). Net income: CN¥603.9m (down 67% from FY 2022). Profit margin: 7.7% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
공시 • Dec 30Lier Chemical Co.,LTD. to Report Fiscal Year 2023 Results on Mar 23, 2024Lier Chemical Co.,LTD. announced that they will report fiscal year 2023 results on Mar 23, 2024
Reported Earnings • Oct 25Third quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.60 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.60 in 3Q 2022). Revenue: CN¥1.54b (down 42% from 3Q 2022). Net income: CN¥80.3m (down 82% from 3Q 2022). Profit margin: 5.2% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.69 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.26 (down from CN¥0.69 in 2Q 2022). Revenue: CN¥2.03b (down 18% from 2Q 2022). Net income: CN¥205.0m (down 60% from 2Q 2022). Profit margin: 10% (down from 21% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 25First quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.72 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.34 (down from CN¥0.72 in 1Q 2022). Revenue: CN¥2.44b (down 6.5% from 1Q 2022). Net income: CN¥274.7m (down 49% from 1Q 2022). Profit margin: 11% (down from 20% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 02Full year 2022 earnings released: EPS: CN¥2.43 (vs CN¥1.46 in FY 2021)Full year 2022 results: EPS: CN¥2.43 (up from CN¥1.46 in FY 2021). Revenue: CN¥10.1b (up 56% from FY 2021). Net income: CN¥1.81b (up 69% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jan 14Full year 2022 earnings released: EPS: CN¥2.43 (vs CN¥1.46 in FY 2021)Full year 2022 results: EPS: CN¥2.43 (up from CN¥1.46 in FY 2021). Revenue: CN¥10.1b (up 56% from FY 2021). Net income: CN¥1.81b (up 69% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. 3 highly experienced directors. Assistant to the General Manager and Member of Supervisory Board Fen Fang Tan is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 13Third quarter 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.14 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.60 (up from CN¥0.14 in 3Q 2021). Revenue: CN¥2.66b (up 138% from 3Q 2021). Net income: CN¥444.5m (up 317% from 3Q 2021). Profit margin: 17% (up from 9.5% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 09Second quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.39 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.39 in 2Q 2021). Revenue: CN¥2.47b (up 47% from 2Q 2021). Net income: CN¥513.3m (up 81% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 11% compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jul 08Second quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.39 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.39 in 2Q 2021). Revenue: CN¥2.47b (up 47% from 2Q 2021). Net income: CN¥513.2m (up 81% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 11% compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥1.01 (vs CN¥0.30 in 1Q 2021)First quarter 2022 results: EPS: CN¥1.01 (up from CN¥0.30 in 1Q 2021). Revenue: CN¥2.61b (up 76% from 1Q 2021). Net income: CN¥534.3m (up 142% from 1Q 2021). Profit margin: 20% (up from 15% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 4.4% compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Apr 06Upcoming dividend of CN¥0.50 per shareEligible shareholders must have bought the stock before 13 April 2022. Payment date: 13 April 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Chinese dividend payers (2.0%). Higher than average of industry peers (1.4%).
Reported Earnings • Mar 06Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥2.04 (up from CN¥1.17 in FY 2020). Revenue: CN¥6.49b (up 31% from FY 2020). Net income: CN¥1.07b (up 75% from FY 2020). Profit margin: 17% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 13%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 33% per year.
Reported Earnings • Jan 23Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥2.04 (up from CN¥1.17 in FY 2020). Revenue: CN¥6.49b (up 31% from FY 2020). Net income: CN¥1.07b (up 75% from FY 2020). Profit margin: 17% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 13%, compared to a 40% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 28% per year.
Valuation Update With 7 Day Price Move • Nov 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥27.56, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 66% over the past three years.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.31 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥1.12b (up 11% from 3Q 2020). Net income: CN¥106.7m (down 34% from 3Q 2020). Profit margin: 9.5% (down from 16% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 15% per year.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥28.25, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 51% over the past three years.
Reported Earnings • Aug 09Second quarter 2021 earnings released: EPS CN¥0.54 (vs CN¥0.33 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.68b (up 23% from 2Q 2020). Net income: CN¥284.2m (up 65% from 2Q 2020). Profit margin: 17% (up from 13% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥30.04, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.77 per share.
Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.16 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.48b (up 51% from 1Q 2020). Net income: CN¥220.8m (up 165% from 1Q 2020). Profit margin: 15% (up from 8.5% in 1Q 2020). The increase in margin was driven by higher revenue.
Analyst Estimate Surprise Post Earnings • Mar 07Revenue beats expectationsRevenue exceeded analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 14%, compared to a 51% growth forecast for the Chemicals industry in China.
Reported Earnings • Mar 07Full year 2020 earnings released: EPS CN¥1.17 (vs CN¥0.59 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.97b (up 19% from FY 2019). Net income: CN¥612.2m (up 97% from FY 2019). Profit margin: 12% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥25.56, the stock is trading at a trailing P/E ratio of 21.8x, down from the previous P/E ratio of 25.8x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past year are 85%.
Is New 90 Day High Low • Feb 20New 90-day high: CN¥30.25The company is up 33% from its price of CN¥22.71 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.22 per share.
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥27.94, the stock is trading at a trailing P/E ratio of 23.8x, up from the previous P/E ratio of 20.3x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 123%.
Is New 90 Day High Low • Jan 29New 90-day high: CN¥25.24The company is up 27% from its price of CN¥19.90 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.21 per share.
Reported Earnings • Jan 23Full year 2020 earnings released: EPS CN¥1.17The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.97b (up 19% from FY 2019). Net income: CN¥615.2m (up 98% from FY 2019). Profit margin: 12% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue.
Analyst Estimate Surprise Post Earnings • Jan 23Revenue beats expectationsRevenue exceeded analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 14%, compared to a 50% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 18% share price gain to CN¥23.71, the stock is trading at a trailing P/E ratio of 25.2x, up from the previous P/E ratio of 21.3x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past year are 109%.
Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥493.5m, up 26% from the prior year. Total revenue was CN¥4.50b over the last 12 months, up 5.2% from the prior year.
Is New 90 Day High Low • Oct 05New 90-day low: CN¥19.38The company is down 2.0% from its price of CN¥19.85 on 07 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.15 per share.